Recent Acquisitions PCI Pharma Services recently acquired Ajinomoto Co., Inc. for $1B, enhancing their US drug product manufacturing capabilities. This acquisition presents a great opportunity to offer expanded services in aseptic filling of prefilled syringes & cartridges to a wider client base.

Innovative Technology PCI Pharma Services' investment in platform enhancements worth $1.2M showcases their commitment to technological advancement. Leveraging their groundbreaking pci | bridge[TM] platform offering real-time supply chain visibility, sales professionals have an opportunity to promote cutting-edge solutions to clients seeking efficiency and automation in product management.

Supply Chain Excellence PCI Pharma Services has been recognized with awards for Supply Chain Excellence and Innovation in the pharmaceutical industry. These accolades position the company as a leader in managing clinical trials and commercial product lifespans. Sales representatives can leverage this reputation to attract clients looking for top-tier supply chain management solutions.

Expansion into Ireland With the recent investment in a pharmaceutical packaging and device assembly facility in Ireland, PCI Pharma Services has expanded its global footprint. Sales professionals can capitalize on this expansion by targeting companies looking for specialized packaging and assembly services in Europe, particularly those seeking large-scale, temperature-controlled storage capabilities.

Industry Recognition PCI Pharma Services' multiple awards in various categories demonstrate their expertise and leadership within the pharmaceutical manufacturing sector. Sales teams can leverage these achievements to build credibility and trust with potential clients, showcasing PCI as a reliable partner for their drug development, manufacturing, and packaging needs.